Kraft Robert O.

Director Kraft sells 6.5K MEDP shares ($3.8M) at $591.85; reduces stake 88.6%, retains only 833 shares post-transaction

Director Robert O. Kraft executed a substantial open-market sale, liquidating 6,472 shares of Medpace Holdings at $591.85 on 2025-11-14, reducing his holdings from 7,305 shares to 833 shares—an 88.6% reduction in position size. The sale occurs near the 52-week high ($605.20, currently -2.5% below peak), following a strong 11.8% rally over the prior 30 days and 26.7% over 90 days. At this same ticker (MEDP), Kraft's prior two 2024 sales realized -6.4% and -6.4% at the 30-day mark with -12.5% and -16.5% 90-day returns respectively, demonstrating pattern of selling ahead of subsequent declines; 2 of his 3 prior MEDP sales were well-timed at the 90-day mark. His cross-ticker track record shows a 66.67% well-timed rate on prior sells, though his most recent same-ticker transactions align with a history of sales executed before pullbacks. The magnitude of this liquidation—retaining only 833 shares—and its execution near recent highs warrant attention to whether the timing again precedes a reversal.

CFO Kraft buys 140,000 HLMN shares at $7.09; holdings up 28.4% to 632,752 shares; stock -36.0% from 52-week high.

Robert O. Kraft, CFO and Treasurer, purchased 140,000 shares of Hillman Solutions at $7.09 on 2025-05-01, increasing his holdings by 28.4% to 632,752 shares for a total commitment of $992,600.00. The current price of $7.38 shows the stock trading 30-day change -7.9% and 90-day change -25.5%, well below its 52-week high of $11.54. Hillman's fundamentals are mixed: revenue of $359.3M declined -0.3% year-over-year, net income turned negative at $-317.0K, and the P/E ratio of 82.00 reflects elevated valuation on depressed earnings. Across Kraft's cross-ticker open-market transaction history, his 3 prior sells show an average 90-day return of -8.5%, with a well-timed rate of 66.67%, indicating his prior sales have generally preceded stock declines. The magnitude of this equity increase and Kraft's historical timing pattern warrant investor attention to whether this signals internal confidence in a turnaround or reflects alternative considerations unknown to the market.

Director Kraft sells 8,127 shares at $390.73 in 2 transactions, reducing stake by 94.0% to 520 shares ($3.2M)

Director Robert O. Kraft executed 2 separate sales totaling 8,127 shares for $3,175,462.71 at a blended average price of $390.73 on 2024-08-22 and 2024-08-23, representing a 94.0% reduction in his holdings at MEDP (from 8,647 shares to 520 shares). The sales occurred when the stock was trading near its 52-week range ($385.30 current price versus $227.52–$457.29 range), approximately 15.7% below the recent high of $457.29. Regarding execution pattern, his prior sale at this ticker on 2023-08-14 saw the stock rise 3.6% over 90 days post-transaction, indicating that prior trade was not well-timed. The company shows strong fundamental momentum with annual revenue growth of +29.2% and a P/E of 35.16, though the near-complete exit of this director's position is noteworthy given the growth trajectory.